Seres Therapeutics names Richard Kender as interim CEO Mar 2, 2026 04:06PM
Bicycle Therapeutics names new CFO and CMO in leadership changes Feb 3, 2026 07:00AM
Oppenheimer on Bicycle Therapeutics (BCYC): 'Near-Term Update Should Sharpen Focus' Jan 20, 2026 06:45AM
Bicycle Therapeutics (BCYC) Reiterated at Market Outperform by Citizens Jan 13, 2026 04:07AM
Bicycle Therapeutics plans dose selection update in first quarter 2026 Jan 12, 2026 07:08AM


Dec 16, 2025 03:57AM Bicycle Therapeutics secures 15-year uranium supply deal for cancer drugs
Nov 24, 2025 07:35AM Truist Securities Starts Bicycle Therapeutics (BCYC) at Hold
Oct 31, 2025 04:33AM Bicycle Therapeutics (BCYC) PT Raised to $12 at Citizens; Cash Position Strong
Oct 31, 2025 02:52AM RBC Capital Downgrades Bicycle Therapeutics (BCYC) to Sector Perform
Oct 30, 2025 07:27AM Bicycle Therapeutics plc (BCYC) Tops Q3 EPS by 23c
Oct 2, 2025 02:22PM Bicycle Therapeutics Plc (BCYC) 3300 contracts of March 10 calls trade
Sep 8, 2025 04:06PM Bicycle Therapeutics adds two directors to board
Aug 12, 2025 04:08AM Bicycle Therapeutics (BCYC) PT Lowered to $10 at Citizens JMP
Aug 11, 2025 09:35AM Bicycle Therapeutics (BCYC) PT Raised to $27 at RBC Capital
Aug 8, 2025 09:46AM Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 20c
May 30, 2025 06:46AM Cantor Fitzgerald Reports Key Takeaways from Call With RadioMedia CEO
May 30, 2025 06:45AM Cantor Fitzgerald reports key Takeaways from call with RadioMedia CEO
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 5, 2025 09:33AM Bicycle Therapeutics (BCYC) PT Raised to $17 at Morgan Stanley
May 2, 2025 05:50AM Bicycle Therapeutics (BCYC) PT Lowered to $22 at Citizens JMP
May 1, 2025 07:07AM Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 3c
Mar 27, 2025 07:03AM Bicycle Therapeutics (BCYC) Announces New Board and Key Clinical Leadership Appointments
Feb 26, 2025 05:08AM Citizens JMP Reiterates Market Outperform Rating on Bicycle Therapeutics (BCYC)
Feb 25, 2025 04:34PM Bicycle Therapeutics plc (BCYC) Tops Q4 EPS by 11c
Feb 25, 2025 02:12PM Bicycle Therapeutics (BCYC) PT Lowered to $42 at Jefferies
Feb 25, 2025 09:45AM Rodman & Renshaw Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Jan 13, 2025 07:03AM Bicycle Therapeutics Plc (BCYC) Announces Updated Topline Zelenectide Pevedotin Data
Dec 16, 2024 07:32AM Bicycle Therapeutics (BCYC) PT Lowered to $17 at B.Riley
Dec 16, 2024 06:51AM Bicycle Therapeutics (BCYC) PT Lowered to $33 at H.C. Wainwright
Dec 13, 2024 12:57PM Morgan Stanley on Equalweight Rated Bicycle Therapeutics (BCYC): 'We view the ~30%+ down move as overdone'
Dec 13, 2024 12:09PM Bicycle Therapeutics (BCYC) PT Lowered to $17 at B.Riley
Nov 26, 2024 07:12AM Needham Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Oct 31, 2024 01:10PM Bicycle Therapeutics (BCYC) PT Raised to $32 at Leerink Partners
Oct 31, 2024 07:08AM Bicycle Therapeutics plc (BCYC) Tops Q3 EPS by 6c
Oct 24, 2024 07:42AM H.C. Wainwright Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Oct 24, 2024 06:37AM Oppenheimer Reiterates Outperform Rating on Bicycle Therapeutics (BCYC)
Oct 24, 2024 06:32AM B.Riley Reiterates Neutral Rating on Bicycle Therapeutics (BCYC)
Oct 23, 2024 07:05AM Bicycle Therapeutics Plc (BCYC) Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceutic
Oct 7, 2024 06:48AM Oppenheimer Reiterates Outperform Rating on Bicycle Therapeutics (BCYC)
Sep 16, 2024 08:43AM TD Cowen Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Sep 16, 2024 07:08AM H.C. Wainwright Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Aug 7, 2024 03:29AM B.Riley Downgrades Bicycle Therapeutics (BCYC) to Neutral
Aug 6, 2024 07:39AM Bicycle Therapeutics plc (BCYC) Tops Q2 EPS by 36c